Personal Information
Entreprise/Lieu de travail
Greater San Diego Area United States
Profession
Director, Clinical Operations
Secteur d’activité
Medical / Health Care / Pharmaceuticals
À propos
Ms. Syto is Director of Clinical Operations at Celgene, where she brings more than 20 years of experience in pharmaceutical development. Prior to joining Celgene, she was Senior Director of Clinical Operations at Tragara Pharmaceuticals, where she was responsible for the implementation and management of multiple Phase I and II oncology clinical trials. Prior to joining Tragara, Ms. Syto successfully led clinical teams in a variety of roles at PAREXEL International, in support of Phase II and III clinical trials for both large pharma and small company clients. Her therapeutic expertise includes dermatology, gastroenterology, immunology, neurology, oncology (hematology and solid tumors).
Présentations
(3)J’aime
(9)CRO and Vendor Oversight: Clinical
Manjusha Chowdhury
•
il y a 7 ans
Sponsor-CRO Relationships
David Selkirk
•
il y a 8 ans
Optimizing Sponsor/CRO Relationships
Brook White, PMP
•
il y a 7 ans
Pharmaceutical Mergers Acquisitions in the U.S
Capgemini
•
il y a 8 ans
What to Do if Your CMS Vendor Got Acquired
DNN
•
il y a 9 ans
Avoca 2014 DIA Presentation
The Avoca Group
•
il y a 9 ans
Lions and Mergers and Acquisitions, OH MY! 5 Steps to an Effective M&A Runbook.
Sirius
•
il y a 10 ans
Reasons For Mergers and Acquisition Failure
Sunidhi Kumari
•
il y a 7 ans
Pharmaceutical Mergs Acquisitions in the US
Capgemini
•
il y a 8 ans
Personal Information
Entreprise/Lieu de travail
Greater San Diego Area United States
Profession
Director, Clinical Operations
Secteur d’activité
Medical / Health Care / Pharmaceuticals
À propos
Ms. Syto is Director of Clinical Operations at Celgene, where she brings more than 20 years of experience in pharmaceutical development. Prior to joining Celgene, she was Senior Director of Clinical Operations at Tragara Pharmaceuticals, where she was responsible for the implementation and management of multiple Phase I and II oncology clinical trials. Prior to joining Tragara, Ms. Syto successfully led clinical teams in a variety of roles at PAREXEL International, in support of Phase II and III clinical trials for both large pharma and small company clients. Her therapeutic expertise includes dermatology, gastroenterology, immunology, neurology, oncology (hematology and solid tumors).